You are here: Industry Insights > Chugai

News List

Chugai Pharma obtains regulatory approval for anti-SARS-CoV-2 monoclonal antibody Ronapreve expresspharma
July 21, 2021
The special approval for emergency under article 14-3 of the Pharmaceuticals and Medical Devices Act was applied to this approval.
EC approves Chugai’s Enspryng for NMOSD treatment pharmaceutical-technology
June 29, 2021
The European Commission (EC) has approved Chugai Pharmaceutical’s Enspryng (satralizumab) to treat anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD).
Chugai ponies up $1B+ to combine R&D operations in Yokohama fiercepharma
May 29, 2019
Chugai expects to finish construction in three years, in August 2022, and the site to be up and running the following January.
Chugai preps filings for IL-6 drug in rare disease, chasing Soliris fiercebiotech
December 20, 2018
Chugai has the positive phase 3 data it needs to file IL-6-targeting antibody satralizumab for approval in neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease, next year.
Anaeropharma, Chugai come together to create Novel Oncology Drugs biospectrumasia
October 23, 2018
Under the agreement, Anaeropharma and Chugai conduct joint research regarding specific oncology substances by use of Anaeropharma's i-DPS technology and Chugai's technology
Lilly’s snaps up Chugai’s experimental diabetes drug pharmatimes
September 29, 2018
Lilly has entered into an agreement to develop Chugai’s OWL833, a oral non-peptidic GLP-1 receptor agonist currently in Phase I for type II diabetes.
Chugai, Nippon Shinyaku bring Gazyva in Japan biospectrumasia
September 03, 2018
Chugai obtained a manufacturing and marketing approval in early July.
Chugai receives Taiwan, China nod for Alecensa biospectrumasia
February 28, 2017
Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan, China has received approval for the anti-cancer agent, alectinib hydrochloride from the Food and Drug Administration of Taiwan, China.